Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rebecca Heist

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Clinical Lung Cancer|September 23, 2023
Improved Survival Outcomes in Patients With MET-Dysregulated Advanced NSCLC Treated With MET Inhibitors: Results of a Multinational Retrospective Chart ReviewJürgen Wolf, Pierre-Jean Souquet, Koichi Goto, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 26, 2022
Phase Ib Study of Telisotuzumab Vedotin in Combination With Erlotinib in Patients With c-Met Protein-Expressing Non-Small-Cell Lung CancerD Ross Camidge, Fabrice Barlesi, Jonathan W Goldman, et al.
JTO Clinical and Research Reports|January 10, 2022
A Phase 1b Study of Telisotuzumab Vedotin in Combination With Nivolumab in Patients With NSCLCD Ross Camidge, Fabrice Barlesi, Jonathan W Goldman, et al.
Investigational New Drugs|January 4, 2020
A phase 2 clinical trial of the heat shock protein 90 (HSP 90) inhibitor ganetespib in patients with refractory advanced esophagogastric cancerLipika Goyal, Surendra Pal Chaudhary, Eunice L Kwak, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 6, 2025
Datopotamab Deruxtecan in Advanced or Metastatic Non-Small Cell Lung Cancer With Actionable Genomic Alterations: Results From the Phase II TROPION-Lung05 StudyJacob Sands, Myung-Ju Ahn, Aaron Lisberg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 9, 2012
Genome-wide association study of prognosis in advanced non-small cell lung cancer patients receiving platinum-based chemotherapyLingmin Hu, Chen Wu, Xueying Zhao, et al.
Biorxiv : the Preprint Server for Biology|September 11, 2023
Structural and functional vascular dysfunction within brain metastases is linked to pembrolizumab inefficacyAlbert E Kim, Kevin W Lou, Anita Giobbie-Hurder, et al.
Neuro-Oncology|December 9, 2023
Abnormal vascular structure and function within brain metastases is linked to pembrolizumab resistanceAlbert E Kim, Kevin W Lou, Anita Giobbie-Hurder, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Clinical Lung Cancer|September 23, 2023
Improved Survival Outcomes in Patients With MET-Dysregulated Advanced NSCLC Treated With MET Inhibitors: Results of a Multinational Retrospective Chart ReviewJürgen Wolf, Pierre-Jean Souquet, Koichi Goto, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 26, 2022
Phase Ib Study of Telisotuzumab Vedotin in Combination With Erlotinib in Patients With c-Met Protein-Expressing Non-Small-Cell Lung CancerD Ross Camidge, Fabrice Barlesi, Jonathan W Goldman, et al.
JTO Clinical and Research Reports|January 10, 2022
A Phase 1b Study of Telisotuzumab Vedotin in Combination With Nivolumab in Patients With NSCLCD Ross Camidge, Fabrice Barlesi, Jonathan W Goldman, et al.
Investigational New Drugs|January 4, 2020
A phase 2 clinical trial of the heat shock protein 90 (HSP 90) inhibitor ganetespib in patients with refractory advanced esophagogastric cancerLipika Goyal, Surendra Pal Chaudhary, Eunice L Kwak, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 6, 2025
Datopotamab Deruxtecan in Advanced or Metastatic Non-Small Cell Lung Cancer With Actionable Genomic Alterations: Results From the Phase II TROPION-Lung05 StudyJacob Sands, Myung-Ju Ahn, Aaron Lisberg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 9, 2012
Genome-wide association study of prognosis in advanced non-small cell lung cancer patients receiving platinum-based chemotherapyLingmin Hu, Chen Wu, Xueying Zhao, et al.
Biorxiv : the Preprint Server for Biology|September 11, 2023
Structural and functional vascular dysfunction within brain metastases is linked to pembrolizumab inefficacyAlbert E Kim, Kevin W Lou, Anita Giobbie-Hurder, et al.
Neuro-Oncology|December 9, 2023
Abnormal vascular structure and function within brain metastases is linked to pembrolizumab resistanceAlbert E Kim, Kevin W Lou, Anita Giobbie-Hurder, et al.
Pageof 2